NASDAQ:LPNT - LifePoint Health Stock Price, Price Target & More

$49.65 -0.40 (-0.80 %)

(As of 04/20/2018 04:00 PM ET)

Previous Close$49.65

Today's Range$48.90 - $50.7750

52-Week Range$41.45 - $67.95

Volume339,996 shs

Average Volume409,424 shs

Market Capitalization$1.95 billion

P/E Ratio13.90

Dividend YieldN/A

Beta0.5

About LifePoint Health (NASDAQ:LPNT)

LifePoint Health, Inc., through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery. The company's hospitals also offer outpatient services comprising same-day surgery, laboratory, X-ray, respiratory therapy, imaging, sports medicine, and lithotripsy. In addition, it owns and operates schools of nursing and other allied health professions. As of December 31, 2017, the company operated 71 hospital campuses with a total of 9,254 licensed beds in 22 states. The company was formerly known as LifePoint Hospitals, Inc. and changed its name to LifePoint Health, Inc. in May 2015. LifePoint Health, Inc. was founded in 1997 and is based in Brentwood, Tennessee.

Receive LPNT News and Ratings via Email

Sign-up to receive the latest news and ratings for LPNT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry General medical & surgical hospitals

Sub-IndustryHealth Care Facilities

SectorMedical

SymbolNASDAQ:LPNT

CUSIP53219L10

Webwww.lifepointhealth.net

Phone615-920-7000

Debt

Debt-to-Equity Ratio1.26%

Current Ratio1.70%

Quick Ratio1.49%

Price-To-Earnings

Trailing P/E Ratio13.90

Forward P/E Ratio11.74

P/E Growth1.52

Sales & Book Value

Annual Sales$7.26 billion

Price / Sales0.27

Cash Flow$12.5379 per share

Price / Cash3.96

Book Value$57.99 per share

Price / Book0.86

Profitability

EPS (Most Recent Fiscal Year)$3.63

Net Income$102.40 million

Net Margins1.46%

Return on Equity6.34%

Return on Assets2.31%

Miscellaneous

Employees42,000

Outstanding Shares38,980,000

How to Become a New Pot Stock Millionaire

LifePoint Health (NASDAQ:LPNT) Frequently Asked Questions

What is LifePoint Health's stock symbol?

LifePoint Health trades on the NASDAQ under the ticker symbol "LPNT."

How will LifePoint Health's stock buyback program work?

LifePoint Health declared that its board has approved a stock buyback program on Friday, October 27th 2017, which authorizes the company to buyback $200,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares buyback programs are generally a sign that the company's board of directors believes its stock is undervalued.

How were LifePoint Health's earnings last quarter?

LifePoint Health (NASDAQ:LPNT) released its quarterly earnings data on Friday, February, 23rd. The company reported $0.77 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.81 by $0.04. The company had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.58 billion. LifePoint Health had a return on equity of 6.34% and a net margin of 1.46%. The firm's revenue was down 7.2% on a year-over-year basis. During the same quarter last year, the company earned $1.07 EPS. View LifePoint Health's Earnings History.

When is LifePoint Health's next earnings date?

LifePoint Health is scheduled to release their next quarterly earnings announcement on Friday, May, 4th 2018. View Earnings Estimates for LifePoint Health.

What guidance has LifePoint Health issued on next quarter's earnings?

LifePoint Health updated its FY18 earnings guidance on Friday, February, 23rd. The company provided earnings per share (EPS) guidance of $4.00-4.53 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.09. The company issued revenue guidance of $6.35-6.43 billion, compared to the consensus revenue estimate of $6.49 billion.

What price target have analysts set for LPNT?

18 analysts have issued 12-month target prices for LifePoint Health's stock. Their forecasts range from $44.00 to $66.00. On average, they anticipate LifePoint Health's stock price to reach $53.0667 in the next year. View Analyst Ratings for LifePoint Health.

What are Wall Street analysts saying about LifePoint Health stock?

Here are some recent quotes from research analysts about LifePoint Health stock:

1. Cantor Fitzgerald analysts commented, "LPNT reported in-line 4Q17 results, with revenue that is short of the FactSet consensus but adjusted EBITDA that was in-line. The company has, however, increased its provision for bad debt, and includes the new, more accurate estimate as an adjustment." (2/23/2018)
2. According to Zacks Investment Research, "LifePoint Health’s stock has underperformed the industry in a year’s time, but its strong Value Score, attractive valuation and upward revision in earnings estimates presents a good investment opportunity. The company’s inorganic growth strategies have aided its overall growth. Disciplined share buyback also provides support to its bottom line. Nevertheless, the company trimmed its 2017 guidance for the second time on a challenging volume environment and weak revenue growth. The company is faced with increasing expenses which has outpaced revenue growth thereby squeezing operating margins. High bad debt is another concern as is declining cash flows." (1/22/2018)

Who are some of LifePoint Health's key competitors?

Some companies that are related to LifePoint Health include Hikma Pharmaceuticals (HKMPF), Aurora Cannabis (ACBFF), FibroGen (FGEN), Abcam (ABCZY), GW Pharmaceuticals (GWPH), Blueprint Medicines (BPMC), Neogen (NEOG), Advanced Accelerator Application (AAAP), Ligand Pharmaceuticals (LGND), BTG (BTGGF), Acadia Healthcare (ACHC), Enerplus (ERF), Amn Healthcare Services (AMN), UDG Healthcare (UDHCF), Spark Therapeutics (ONCE), Array Biopharma (ARRY), Inogen (INGN) and Tesaro (TSRO).

Who are LifePoint Health's key executives?

LifePoint Health's management team includes the folowing people:

Mr. William F. Carpenter III, Chairman & CEO (Age 63)
Mr. David M. Dill, Pres & COO (Age 49)
Mr. Michael S. Coggin, Exec. VP, CFO & Principal Accounting Officer (Age 48)
Mr. John P. Bumpus, Exec. VP & Chief Admin. Officer (Age 57)
Mr. Sean Tuley, Chief Information Officer

Has LifePoint Health been receiving favorable news coverage?

Press coverage about LPNT stock has trended positive this week, according to Accern. The research firm ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. LifePoint Health earned a news sentiment score of 0.42 on Accern's scale. They also gave news articles about the company an impact score of 46.63 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

How do I buy shares of LifePoint Health?

Shares of LPNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is LifePoint Health's stock price today?

One share of LPNT stock can currently be purchased for approximately $49.65.

How big of a company is LifePoint Health?

LifePoint Health has a market capitalization of $1.95 billion and generates $7.26 billion in revenue each year. The company earns $102.40 million in net income (profit) each year or $3.63 on an earnings per share basis. LifePoint Health employs 42,000 workers across the globe.

How can I contact LifePoint Health?

LifePoint Health's mailing address is 330 Seven Springs Way, Brentwood TN, 37027. The company can be reached via phone at 615-920-7000 or via email at [email protected]

MarketBeat Community Rating for LifePoint Health (LPNT)

Community Ranking:		2.0 out of 5 ( )
Outperform Votes:		301 (Vote Outperform)
Underperform Votes:		468 (Vote Underperform)
Total Votes:		769

MarketBeat's community ratings are surveys of what our community members think about LifePoint Health and other stocks. Vote "Outperform" if you believe LPNT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LPNT will underperform the S&P 500 over the long term. You may vote once every thirty days.

LifePoint Health (NASDAQ:LPNT) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

18 Wall Street analysts have issued ratings and price targets for LifePoint Health in the last 12 months. Their average twelve-month price target is $53.0667, suggesting that the stock has a possible upside of 6.88%. The high price target for LPNT is $66.00 and the low price target for LPNT is $44.00. There are currently 1 sell rating, 11 hold ratings and 6 buy ratings for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Hold	Hold
Consensus Rating Score:	2.28	2.26	2.24	2.07
Ratings Breakdown:	1 Sell Rating(s) 11 Hold Rating(s) 6 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 12 Hold Rating(s) 6 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 11 Hold Rating(s) 5 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 10 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$53.0667	$54.0625	$58.0769	$64.9167
Price Target Upside:	6.88% upside	8.89% upside	14.10% upside	16.34% upside

LifePoint Health (NASDAQ:LPNT) Consensus Price Target History

Price Target History for LifePoint Health (NASDAQ:LPNT)

LifePoint Health (NASDAQ:LPNT) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
3/27/2018	Robert W. Baird	Reiterated Rating	Buy	$54.00	Medium
3/23/2018	Mizuho	Initiated Coverage	Neutral		High
3/16/2018	Wolfe Research	Upgrade	Underperform -> Peer Perform		Medium
3/15/2018	Raymond James	Upgrade	Market Perform -> Outperform	$57.00	High
3/15/2018	UBS	Upgrade	Market Perform -> Outperform		High
3/5/2018	Leerink Swann	Downgrade	Outperform -> Market Perform	$46.30 -> $58.00	Medium
2/26/2018	SunTrust Banks	Lower Price Target	Hold	$44.00	High
2/26/2018	Royal Bank of Canada	Lower Price Target	Outperform	$58.00	High
2/26/2018	BMO Capital Markets	Lower Price Target	Market Perform	$47.00	High
2/26/2018	Credit Suisse Group	Reiterated Rating	Neutral -> Neutral	$54.00 -> $48.00	High
2/26/2018	Morgan Stanley	Reiterated Rating	Equal Weight -> Equal Weight	$50.00 -> $46.00	High
2/23/2018	Cantor Fitzgerald	Reiterated Rating	Hold	$50.00	High
1/30/2018	Wells Fargo	Initiated Coverage	Market Perform -> Market Perform	$52.00	High
1/3/2018	Goldman Sachs	Initiated Coverage	Sell -> Sell	$45.00	High
11/21/2017	William Blair	Reiterated Rating	Outperform		N/A
10/30/2017	Citigroup	Lower Price Target	Buy	$70.00 -> $60.00	N/A
10/29/2017	KeyCorp	Reiterated Rating	Hold		N/A
10/4/2017	Piper Jaffray	Reiterated Rating	Hold	$66.00	Medium
5/1/2017	Barclays	Boost Price Target	Equal Weight	$58.00 -> $60.00	Low
4/4/2017	Deutsche Bank	Initiated Coverage	Hold -> Hold	$68.00	Low
11/9/2016	Avondale Partners	Downgrade	Outperform -> Market Perform		N/A
11/9/2016	Bank of America	Downgrade	Neutral -> Underperform	$66.00 -> $59.00	N/A
8/1/2016	Wedbush	Reiterated Rating	Neutral	$80.00 -> $66.00	N/A
5/16/2016	Sterne Agee CRT	Reiterated Rating	Buy		N/A

(Data available from 4/21/2016 forward)

LifePoint Health (NASDAQ:LPNT) Earnings History and Estimates Chart

Earnings by Quarter for LifePoint Health (NASDAQ:LPNT)

LifePoint Health (NASDAQ:LPNT) Earnings Estimates

2018 EPS Consensus Estimate: $4.20
2019 EPS Consensus Estimate: $4.47

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	3	$1.01	$1.13	$1.07
Q2 2018	3	$0.96	$1.10	$1.04
Q3 2018	3	$0.99	$1.05	$1.01
Q4 2018	3	$0.98	$1.13	$1.07
Q1 2019	2	$1.13	$1.20	$1.17
Q2 2019	2	$1.03	$1.14	$1.09
Q3 2019	2	$1.05	$1.07	$1.06
Q4 2019	1	$1.16	$1.16	$1.16

LifePoint Health (NASDAQ LPNT) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/4/2018		$1.13					N/A
4/26/2018							N/A
2/23/2018	Q4 2017	$0.81	$0.77	$1.5803 billion	$1.4904 billion	View	Listen
10/27/2017	Q3 2017	$0.95	$0.80	$1.6035 billion	$1.5760 billion	View	N/A
8/1/2017	Q2 2017	$0.90	$0.96	$1.6352 billion	$1.5948 billion	View	Listen
4/28/2017	Q1 2017	$1.0120	$1.07	$1.6355 billion	$1.6302 billion	View	N/A
2/17/2017	Q4 2016	$1.07	$1.09	$1.6332 billion	$1.6052 billion	View	N/A
10/28/2016	Q316	$0.84	$0.94	$1.59 billion	$1.59 billion	View	Listen
7/29/2016	Q216	$0.90	$0.71	$1.61 billion	$1.59 billion	View	Listen
4/29/2016	Q1	$0.88	$0.87	$1.57 billion	$1.58 billion	View	Listen
2/12/2016	Q415	$1.06	$1.11	$1.3857 billion	$1.37 billion	View	Listen
10/30/2015	Q315	$0.90	$0.94	$1.30 billion	$1.31 billion	View	Listen
7/31/2015	Q215	$0.98	$1.00	$1.24 billion	$1.27 billion	View	Listen
5/1/2015	Q115	$1.00	$1.00	$1.24 billion	$1.26 billion	View	Listen
2/12/2015	Q414	$1.01	$1.08	$1.25 billion	$1.26 billion	View	Listen
10/24/2014	Q314	$0.74	$0.75	$1.09 billion	$1.38 billion	View	Listen
7/25/2014	Q214	$0.55	$0.84	$1.01 billion	$1.05 billion	View	Listen
4/25/2014	Q114	$0.65	$0.65	$1,000.00 million	$1.0072 billion	View	Listen
2/14/2014	Q413	$0.80	$0.75	$952.10 million	$952.60 million	View	Listen
10/25/2013	Q313	$0.66	$0.68	$891.30 million	$899.70 million	View	Listen
7/26/2013	Q2 2013	$0.72	$0.65	$911.08 million	$894.90 million	View	Listen
4/26/2013	Q1 2013	$0.81	$0.69	$924.00 million	$931.10 million	View	Listen
2/15/2013	Q4 2012	$0.65	$0.76	$863.49 million	$893.30 million	View	Listen
10/26/2012	Q312	$0.76	$0.39	$814.52 million	$820.20 million	View	N/A
7/27/2012		$0.80	$0.83			View	N/A
4/27/2012		$0.91	$0.94			View	N/A
2/17/2012	Q4 2011	$0.76	$0.78			View	N/A
10/28/2011		$0.71	$0.77			View	N/A
7/29/2011		$0.75	$0.77			View	N/A
4/29/2011		$0.81	$0.89			View	N/A
2/18/2011		$0.67	$0.70			View	N/A
10/29/2010	Q3 2010	$0.66	$0.73			View	N/A
8/2/2010	Q2 2010	$0.63	$0.69			View	N/A
4/30/2010	Q1 2010	$0.75	$0.80			View	N/A
2/19/2010	Q4 2009	$0.60	$0.73			View	N/A
11/6/2009	Q3 2009	$0.56	$0.59			View	N/A
8/7/2009	Q2 2009	$0.58	$0.54			View	N/A
5/1/2009	Q1 2009	$0.64	$0.74			View	N/A
2/20/2009	Q4 2008	$0.63	$0.63			View	N/A
11/7/2008	Q3 2008	$0.60	$0.61			View	N/A
8/8/2008	Q2 2008	$0.56	$0.60			View	N/A
5/1/2008	Q1 2008	$0.61	$0.72			View	N/A
2/8/2008	Q4 2007	$0.58	$0.54			View	N/A

(Earnings results data provided by Zacks Investment Research)

LifePoint Health (NASDAQ:LPNT) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

LifePoint Health (NASDAQ LPNT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 8.76%

Insider Trading History for LifePoint Health (NASDAQ:LPNT)

LifePoint Health (NASDAQ LPNT) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/28/2018	William F Carpenter III	Chairman	Buy	21,368	$46.80	$1,000,022.40	482,668
1/16/2018	David M Dill	Insider	Sell	45,000	$48.52	$2,183,400.00	252,673
11/28/2017	Marguerite Kondracke	Director	Sell	3,907	$44.73	$174,760.11
11/21/2017	Marguerite Kondracke	Director	Sell	3,416	$43.80	$149,620.80	17,479
7/17/2017	William F Carpenter III	Chairman	Sell	17,653	$65.06	$1,148,504.18	439,841
6/15/2017	William F Carpenter III	Chairman	Sell	82,347	$64.15	$5,282,560.05	504,535
5/11/2017	Richard H Evans	Director	Sell	2,000	$62.88	$125,760.00	17,718
3/30/2017	John P Bumpus	EVP	Sell	33,333	$65.00	$2,166,645.00	143,829
3/16/2017	David M Dill	Insider	Sell	18,800	$62.22	$1,169,736.00	207,873
3/10/2017	David M Dill	Insider	Sell	1,200	$65.00	$78,000.00	208,773
3/9/2017	John P Bumpus	EVP	Sell	26,362	$65.05	$1,714,848.10	117,458
3/6/2017	John P Bumpus	EVP	Sell	305	$65.00	$19,825.00	110,701
5/25/2016	John E D D S Maupin Jr	Director	Sell	3,800	$67.32	$255,816.00	22,813
2/18/2016	Gregory T Bier	Director	Sell	2,149	$63.00	$135,387.00	21,339
5/7/2015	Owen G Shell Jr	Director	Sell	7,500	$70.69	$530,175.00
3/9/2015	John E D D S Maupin Jr	Director	Sell	1,300	$72.50	$94,250.00
2/23/2015	Michael S Coggin	SVP	Sell	5,000	$70.50	$352,500.00
9/9/2014	Marguerite Kondracke	Director	Sell	1,500	$72.43	$108,645.00
7/31/2014	Leif M Murphy	CFO	Sell	100,000	$72.03	$7,203,000.00
6/12/2014	Richard H Evans	Director	Sell	1,000	$64.05	$64,050.00
5/16/2014	William Carpenter III	CEO	Sell	280,849	$58.11	$16,320,135.39	374,492
5/13/2014	Paul Gilbert	EVP	Sell	54,342	$59.21	$3,217,589.82	20,000
5/7/2014	John Bumpus	EVP	Sell	20,000	$57.20	$1,144,000.00	97,901
3/12/2014	Marguerite Kondracke	Director	Sell	2,000	$51.49	$102,980.00	23,145
12/5/2013	Paul Gilbert	EVP	Sell	12,825	$51.12	$655,614.00	40,000
10/31/2013	Michael S Coggin	SVP	Sell	2,000	$51.14	$102,280.00
10/30/2013	William F Carpenter III	CEO	Sell	40,000	$51.31	$2,052,400.00
8/1/2013	Michael Coggin	SVP	Sell	2,452	$50.00	$122,600.00	12,435
6/6/2013	Paul D Gilbert	EVP	Sell	16,667	$51.01	$850,183.67
5/20/2013	Richard H Evans	Director	Sell	4,275	$47.50	$203,062.50
2/25/2013	Michael S Coggin	SVP	Sell	6,668	$44.03	$293,592.04
2/25/2013	Richard H Evans	Director	Sell	5,000	$43.31	$216,550.00
9/14/2012	Marguerite Sallee	Director	Sell	3,000	$42.36	$127,080.00
8/21/2012	Michael S Coggin	SVP	Sell	6,666	$41.00	$273,306.00
8/21/2012	William F Carpenter III	CEO	Sell	50,000	$41.02	$2,051,000.00

(Data available from 1/1/2013 forward)

LifePoint Health (NASDAQ LPNT) News Headlines

Source:

Date	Headline
	LifePoint Health To Broadcast Its First Quarter 2018 Conference Call Live On The Internet finance.yahoo.com - April 20 at 4:42 PM
	LifePoint Health (LPNT) Scheduled to Post Quarterly Earnings on Thursday www.americanbankingnews.com - April 19 at 2:52 AM
	$1.61 Billion in Sales Expected for LifePoint Health (LPNT) This Quarter www.americanbankingnews.com - April 16 at 2:17 AM
	LifePoint Health (LPNT) Expected to Announce Earnings of $1.10 Per Share www.americanbankingnews.com - April 14 at 9:15 PM
	BidaskClub Downgrades LifePoint Health (LPNT) to Sell www.americanbankingnews.com - April 14 at 5:18 PM
	LifePoint Health (LPNT) Rating Reiterated by Piper Jaffray www.americanbankingnews.com - April 7 at 11:00 PM
	LifePoint Health (LPNT) Earns "Hold" Rating from KeyCorp www.americanbankingnews.com - April 4 at 3:32 PM
	LifePoint Health (LPNT) Given a $55.00 Price Target by Robert W. Baird Analysts www.americanbankingnews.com - April 4 at 2:27 PM
	Castleview Hospital Named Duke LifePoint Quality Affiliate finance.yahoo.com - April 3 at 4:43 PM
	Leerink Swann Reiterates "Outperform" Rating for LifePoint Health (LPNT) www.americanbankingnews.com - April 2 at 9:11 PM
	LifePoint Health (LPNT) Given a $54.00 Price Target at SunTrust Banks www.americanbankingnews.com - April 2 at 8:04 PM
	LifePoint Health Inc (LPNT) Receives Average Recommendation of "Hold" from Brokerages www.americanbankingnews.com - March 31 at 11:34 AM
	$1.61 Billion in Sales Expected for LifePoint Health Inc (LPNT) This Quarter www.americanbankingnews.com - March 30 at 1:50 AM
	Robert W. Baird Reiterates $54.00 Price Target for LifePoint Health (LPNT) www.americanbankingnews.com - March 27 at 1:18 PM
	Wells Fargo Begins Coverage on LifePoint Health (LPNT) www.americanbankingnews.com - March 26 at 3:43 PM
	Why Is LifePoint Health (LPNT) Down 2.9% Since its Last Earnings Report? www.zacks.com - March 26 at 9:35 AM
	LifePoint Health (LPNT) Upgraded to "Buy" at BidaskClub www.americanbankingnews.com - March 24 at 4:30 PM
	LifePoint Health (LPNT) Earns Neutral Rating from Analysts at Mizuho www.americanbankingnews.com - March 23 at 6:50 PM
	Is There Now An Opportunity In LifePoint Health Inc (NASDAQ:LPNT)? finance.yahoo.com - March 23 at 9:09 AM
	LifePoint Health (LPNT) Earns Hold Rating from Mizuho www.americanbankingnews.com - March 22 at 9:20 PM
	UBS Upgrades LifePoint Health (LPNT) to "Outperform" www.americanbankingnews.com - March 17 at 12:32 PM
	LifePoint Health, Inc. -- Moody's affirms LifePoint's Ba2 CFR, stable outlook finance.yahoo.com - March 16 at 5:40 PM
	LifePoint Health (LPNT) Upgraded at Wolfe Research www.americanbankingnews.com - March 16 at 2:09 PM
	Raymond James Financial Upgrades LifePoint Health (LPNT) to Outperform www.americanbankingnews.com - March 15 at 9:58 PM
	LifePoint Health Inc (NASDAQ:LPNT): Does The Earnings Decline Make It An Underperformer? finance.yahoo.com - March 15 at 9:04 AM
	LifePoint Health Named Recipient of 2017 John M. Eisenberg Award for Innovation in Patient Safety finance.yahoo.com - March 13 at 9:27 AM
	LifePoint Health Inc (LPNT) Expected to Announce Quarterly Sales of $1.61 Billion www.americanbankingnews.com - March 13 at 3:36 AM
	FY2018 Earnings Forecast for LifePoint Health Inc Issued By Leerink Swann (LPNT) www.americanbankingnews.com - March 7 at 11:51 AM
	LifePoint Health Inc (LPNT) Given Average Recommendation of "Hold" by Brokerages www.americanbankingnews.com - March 6 at 11:50 AM
	LifePoint Health Inc Expected to Earn Q1 2018 Earnings of $1.08 Per Share (LPNT) www.americanbankingnews.com - March 6 at 7:06 AM
	Leerink Swann Lowers LifePoint Health (LPNT) to Market Perform www.americanbankingnews.com - March 5 at 5:34 PM
	After A Q4 Miss, LifePoint Health Downgraded By Leerink On Free Cash Flow Concerns finance.yahoo.com - March 5 at 5:13 PM
	LifePoint Health Inc (LPNT) Position Trimmed by Arrowstreet Capital Limited Partnership www.americanbankingnews.com - March 4 at 4:32 AM
	WINTON GROUP Ltd Buys 99,104 Shares of LifePoint Health Inc (LPNT) www.americanbankingnews.com - March 3 at 3:15 PM
	LifePoint Health Inc (LPNT) Chairman Purchases $1,000,022.40 in Stock www.americanbankingnews.com - March 2 at 12:14 PM
	LifePoint Health Inc (LPNT) Shares Bought by California Public Employees Retirement System www.americanbankingnews.com - March 2 at 5:20 AM
	Georgetown Community Hospital Named Duke LifePoint Quality Affiliate finance.yahoo.com - March 1 at 5:02 PM
	Cantor Fitzgerald Brokers Boost Earnings Estimates for LifePoint Health Inc (LPNT) www.americanbankingnews.com - February 28 at 11:46 AM
	Research Analysts Issue Forecasts for LifePoint Health Inc's Q1 2018 Earnings (LPNT) www.americanbankingnews.com - February 27 at 6:44 AM
	LifePoint Health (LPNT) Price Target Cut to $46.00 by Analysts at Morgan Stanley www.americanbankingnews.com - February 26 at 4:52 PM
	LifePoint Health Inc (LPNT) Stake Increased by Systematic Financial Management LP www.americanbankingnews.com - February 26 at 3:57 PM
	SunTrust Banks Cuts LifePoint Health (LPNT) Price Target to $44.00 www.americanbankingnews.com - February 26 at 2:42 PM
	BMO Capital Markets Trims LifePoint Health (LPNT) Target Price to $47.00 www.americanbankingnews.com - February 26 at 2:42 PM
	LifePoint Health (LPNT) Price Target Cut to $58.00 by Analysts at Royal Bank of Canada www.americanbankingnews.com - February 26 at 2:42 PM
	LifePoint Health (LPNT) Stock Rating Reaffirmed by Credit Suisse Group www.americanbankingnews.com - February 26 at 1:10 PM
	First Trust Advisors LP Has $20.63 Million Position in LifePoint Health Inc (LPNT) www.americanbankingnews.com - February 26 at 9:04 AM
	$1.57 Billion in Sales Expected for LifePoint Health Inc (LPNT) This Quarter www.americanbankingnews.com - February 24 at 1:06 AM
	LifePoint Health (LPNT) CEO Bill Carpenter on Q4 2017 Results - Earnings Call Transcript seekingalpha.com - February 23 at 5:09 PM
	LifePoint Health (LPNT) Posts Quarterly Earnings Results, Misses Estimates By $0.06 EPS www.americanbankingnews.com - February 23 at 12:00 PM
	LifePoint Health (LPNT) Updates FY18 Earnings Guidance www.americanbankingnews.com - February 23 at 9:16 AM

LifePoint Health (NASDAQ:LPNT) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

LifePoint Health (NASDAQ:LPNT) Income Statement, Balance Sheet and Cash Flow Statement

LifePoint Health (NASDAQ LPNT) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff